by Combat Cancer | May 31, 2025 | News
Combat Medical is proud to announce that our Phase 3 clinical trial of HIVEC®-HEAT for patients with BCG-unresponsive non-muscle-invasive bladder cancer, has received ethical and MHRA (Medicines and Healthcare products Regulatory) approval. HIVEC®-HEAT has also been...
by Combat Cancer | May 24, 2025 | News
New Game-Changing, UK-Based Technological Innovation: The miONCO-Dx Cancer Test An inexpensive blood test that can identify the presence of 12 of the most common and lethal cancers – including cancer of the bladder and bowel – at an early stage, with over 99% accuracy...
by Combat Cancer | May 17, 2025 | News
Did you know that long-term use of urinary catheters increases the risk of bladder cancer, especially in those aged 45-60? Bladder cancer is one of the most commonly diagnosed cancers of the urinary system, and while smoking remains a major risk factor, new evidence...
by Combat Cancer | May 10, 2025 | News
While smoking remains the leading preventable risk factor for bladder cancer, and indeed most cancers, a lesser-known but significant contributor is workplace exposure to carcinogenic chemicals. In the UK, Cancer Research UK (CRUK) estimates that approximately 6% of...
by Combat Cancer | May 2, 2025 | News
In recent years, the potential role of vitamin D in preventing and treating colorectal cancer (CRC) has attracted increasing attention within the medical community. And now, a comprehensive 2025 review published in Nutrients by Fekete et al.* suggests that this humble...
Recent Comments